£686k
−47%vs Jun 2024Active12662440Private limited companyLondon
SALIENT LABS LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Salient Labs Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Salient Labs Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
SALIENT LABS LIMITED is an active private limited company (company number 12662440) incorporated on 11 June 2020, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of £686k and cash of £73k, with 15 employees on average. Net assets fell 47% on the prior period (£1.30m).
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
No active person with significant control is registered.
- Dr Marta Ciechonska
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Miles Priestman
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr Jack Priestman
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Jp-1 Yggdrasil Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Jack Priestman
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Miles Priestman
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Marta Ciechonska
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 11 June 20206 yrs ago
- Next accounts due
- 30 March 2027in 155 days
- Confirmation statement due
- 25 June 2027in 242 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£73k
−89%vs Jun 2024Not reported
15
No changevs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £686k | £73k | — | £131k | — | — | 15 |
| 30 June 2024 | £1.30m | £672k | — | £103k | — | — | 15 |
Current ratio4.31Current assets ÷ creditors within one year
Cash per employee£4,852Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £685,958 at 30 June 2025
- Net assets down 25% or more on the prior period-47.2% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 4.31
- Cash at bank of £50,000 or moreCash £72,781
- Incorporated five or more years agoIncorporated 11 June 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 242 days
- Next accounts duein 155 days
- Accounts period endNet assets £686k · small accounts
- Accounts period endNet assets £1.30m · small accounts
- Incorporated
08
Similar companies in London
- EVOLV SCIENCES LIMITEDLondon · inc. Jun 2020
- LUAS DIAGNOSTICS LTDLondon · inc. Jun 2020
- TOWER THERAPEUTICS LIMITEDLondon · inc. Jun 2020
- THE STEM CELL LAB LTDLondon · inc. Jun 2020
- DINGYUN BIOTECH CO. LIMITEDLondon · inc. Jun 2020
- SIMPLY ENZYMES LIMITEDLondon · inc. Jun 2020
All companies incorporated on 11 June 2020 · in Jun 2020.
09
Reminders for SALIENT LABS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.